Giora Davidai
Overview
Explore the profile of Giora Davidai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsueh W, Davidai G, Henry R, Mudaliar S
J Clin Hypertens (Greenwich)
. 2010 Oct;
12(9):746-52.
PMID: 20883237
Angiotensin receptor blockers (ARBs) are antihypertensive agents associated with reduced risk of new-onset diabetes mellitus. The ARB telmisartan is a partial agonist of peroxisome proliferator-activated receptor-gamma (PPAR-γ). This study evaluated...
2.
Wells T, Portman R, Norman P, Haertter S, Davidai G, Wang F
Clin Pediatr (Phila)
. 2010 Aug;
49(10):938-46.
PMID: 20724342
Objective: To assess the safety, pharmacokinetics (PKs), and blood pressure (BP)-lowering efficacy of telmisartan in pediatric (6 to <18 years) patients with hypertension. Study Design: Patients with diagnosed hypertension were...
3.
Bakris G, Burgess E, Weir M, Davidai G, Koval S
Kidney Int
. 2008 May;
74(3):364-9.
PMID: 18496508
In patients with diabetic nephropathy, lowering blood pressure and reducing proteinuria by over 30% correlates with a slower progression to kidney failure. We compared two different angiotensin receptor-blockers in a...
4.
White W, Murwin D, Chrysant S, Koval S, Davidai G, Guthrie R
Blood Press Monit
. 2008 Jan;
13(1):21-7.
PMID: 18199920
In 2004-2005, the antihypertensive effects of telmisartan 80 mg versus valsartan 160 mg combined with hydrochlorothiazide 25 mg were assessed in a large placebo-controlled trial in patients with stages 1...
5.
Gosse P, Neutel J, Schumacher H, Lacourciere Y, Williams B, Davidai G
Blood Press Monit
. 2007 May;
12(3):141-7.
PMID: 17496463
Objectives: The period of early morning blood pressure surge is associated with a higher incidence of cardiovascular events than at other times of the day. Antihypertensive medication given once daily...
6.
Schapira A, Bezard E, Brotchie J, Calon F, Collingridge G, Ferger B, et al.
Nat Rev Drug Discov
. 2006 Oct;
5(10):845-54.
PMID: 17016425
Dopamine deficiency, caused by the degeneration of nigrostriatal dopaminergic neurons, is the cause of the major clinical motor symptoms of Parkinson's disease. These symptoms can be treated successfully with a...
7.
White W, Punzi H, Murwin D, Koval S, Davidai G, Neutel J
J Clin Hypertens (Greenwich)
. 2006 Sep;
8(9):626-33.
PMID: 16957424
To attain recent goals of blood pressure (BP) control, multiple drug therapy combinations are required, including higher doses of thiazide diuretics in combination with other classes of antihypertensive drug therapy....
8.
Flannery M, Ramsdell J, Ranhosky A, Davidai G, Ruoff G
Curr Med Res Opin
. 2006 May;
22(4):721-30.
PMID: 16684433
Objective: This study evaluated the efficacy and safety of the alpha(1A)/alpha(1D) subtype-selective blocker tamsulosin for the increasingly common treatment of benign prostatic hyperplasia (BPH) in the primary care setting. Methods:...
9.
Weber M, White W, Giles T, Bakris G, Neutel J, Smith D, et al.
J Clin Hypertens (Greenwich)
. 2006 Apr;
8(4):241-50.
PMID: 16596026
Effectiveness trials in hypertension enable the efficacy and safety of new drugs to be compared with previous therapy. Since these open-label trials could inadvertently be influenced by observer bias, this...
10.
White W, Giles T, Bakris G, Neutel J, Davidai G, Weber M
Am Heart J
. 2005 Dec;
151(1):176-84.
PMID: 16368314
Background: Traditional clinical trials in hypertension measure the efficacy of antihypertensive drugs but may not fully assess their effectiveness in clinical practice. Community-based trials can provide this information but are...